Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer
3531.6000 -34.60 (-0.97%)
NSE Sep 15, 2025 15:31 PM
Volume: 158.7K
 

3531.60
-0.97%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 20.1% YoY to | 1722 crore (I-direct estimate: | 1763 crore) mainly due to 48.4% YoY growth in Indian formulations to | 693 crore (I-direct estimate: | 733 crore) led by consolidation of the Unichem India and Nepal businesses EBITDA margins improved 57 bps YoY to 21.1% YoY (I-direct estimate: 24.5%). Improvement in gross margins (73.1% vs 65.8% in Q4FY18) was largely offset by higher other expenditure. EBITDA...
Torrent Pharmaceuticals Ltd.'s price crossed below 50Day SMA today
More from Torrent Pharmaceu…
All earning calls
Investor presentations from Torrent Pharmaceu…
All investor presentations